Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Barnes & Noble Education Announces Expanded Library of Digital Courseware in Criminal Justice

Published

on

Reading Time: 4 minutes

BASKING RIDGE, N.J.–(BUSINESS WIRE)–Barnes
& Noble Education, Inc. (NYSE: BNED)
, a leading provider of
educational products and services solutions for higher education and
K-12 institutions, today announced it has expanded its library of BNC
OER+
digital courseware to include 10 criminal justice courses.

Access to affordable learning materials remains a significant barrier to
student engagement in higher education. While instructors in many
academic disciplines have begun to adopt lower cost materials to support
student affordability, criminal justice professors have had fewer
high-quality, low-cost options available in their discipline, making
these materials more difficult to adopt.

Priced at $25 per student, BNC OER+, formerly known as LoudCloud
Courseware, blends open educational resources (“OER”) and originally
authored content with a full range of ancillary materials, such as
auto-graded practice problems, summative exams and homework activities.
The courseware is highly customizable, empowering faculty to easily
personalize their course material. Powered with analytics, the platform
also provides integrated insights, enabling both students and their
faculty to monitor performance and improve learning outcomes.

In talking with various faculty members, we recognized an increased
need for more low-cost, customizable content in the criminal justice
discipline, and felt it was important to expand our library of
courseware content to further drive affordability, accessibility and
achievement for these students and faculty,” said Sesha Bolisetty, Head
of Content Operations, BNED. “We look forward to partnering with
additional faculty members in the coming semesters to deliver these
engaging digital courses in the criminal justice field.”

According to a recent BNC OER+ user survey, more than 90 percent of
students found the courseware content to be helpful in understanding the
subject matter better. More than 85 percent of students felt the
courseware platform interface was easy to use.

BNC OER+ has been well-received among faculty members leveraging the
criminal justice material for their courses. Feedback includes:

  • I have utilized the BNC OER+ platform at Penn State Beaver for two
    semesters. My students have found the platform easy to access,
    engaging, and they love the affordability. They particularly enjoy the
    videos directly linked to their readings. As a professor, I am excited
    that I can tailor the material to my lectures and state specific
    laws, issues, and current events while having a strong foundation
    already established in the platform. This provides me the opportunity
    to increase engagement and, ultimately, retention.” – Jodi Ann
    Gill, Criminal Justice Instructor, Penn State Beaver
  • The Juvenile Delinquency course was developed by a team
    of experts who are actively teaching the subject and know firsthand
    the complexity of its themes in both the classroom and online
    settings. The course’s design is student-centered, explaining the
    factors that contribute to juvenile delinquency and the process that
    juveniles face once in the juvenile justice system, in a clear and
    concise way. The course also includes thought-provoking learning
    resources such as videos, discussion questions and assignments to help
    instructors meet the learning objectives of the course. This course is
    a great platform for both instructors and administrators looking to
    update their Criminal Justice courses offered at their institution.” – Glenda
    Torrealba, MCJ, Hillsborough Community College & Ana G. Mendez
    University
  • Being able to rely on a rich set of course materials to use as a
    starting point is tremendously helpful, especially for professors who
    are teaching a new topic for the first time or who teach a topic only
    occasionally. The Homeland Security course is a good example. It
    provides a baseline package that our adjuncts can ‘grab and go fast.’
    It also helps ensure that the course is consistent from semester to
    semester, and that it delivers the essential prerequisite baseline
    knowledge that is important for our more advanced courses. No matter
    who is teaching the course, we know the content will be right. BNED’s
    courses contain rich material that is relevant, visually appealing and
    easy to use.” — Dr. Daniel T. Murphy, Massachusetts Maritime Academy
  • Introduction to Criminal Law provides an excellent foundation for
    anyone interested in examining the topic. The reader is provided with
    the historical building blocks of criminal law and a tour through its
    development in the United States. Most importantly, the text provides
    an understanding of how individual criminal statutes are created,
    interpreted and applied. As a practitioner as well as an academic, I
    believe a student of criminal justice needs to understand how the
    criminal laws are actually applied by law enforcement and our federal
    and state courts. This text offers a balance between the theoretical
    approach and ‘real world’ impact of criminal law.” — Roger Wright,
    Professor Emeritus, University of Cincinnati Criminal Justice

BNC OER+ criminal justice course offerings include:

  • Introduction to Criminal Justice
  • Criminal Investigation
  • Homeland Security
  • Victimology
  • Police Function
  • Criminal Procedure
  • Introduction to Criminal Law
  • Criminology
  • Correction Institutions
  • Juvenile Delinquency

All courses are available now for immediate use and class adoptions.

To learn more about BNC OER+ or to request a demo, visit: www.bncoerplus.com
or contact [email protected].

ABOUT BARNES & NOBLE EDUCATION, INC.

Barnes & Noble Education, Inc. (NYSE: BNED) is a leading
provider of higher education and K-12 educational products and
solutions. Through its Barnes & Noble College and MBS Textbook Exchange
segments, Barnes & Noble Education operates 1,453 physical and virtual
bookstores across the U.S., serving more than 6 million students and
faculty. Through its Digital Student Solutions segment, the Company
offers direct-to-student products and services that help students study
more effectively and improve academic performance, enabling them to gain
the valuable skills necessary to succeed after college. The Company also
operates one of the largest textbook wholesale distribution channels in
the United States. For more information please visit www.bned.com.

BNED companies include: Barnes
& Noble College Booksellers, LLC
, MBS
Textbook Exchange, LLC
, BNED
LoudCloud, LLC
, Student
Brands, LLC
, Promoversity,
LLC
, and PaperRater,
LLC
. General information on Barnes & Noble Education may be obtained
by visiting the Company’s corporate website: www.bned.com.

Contacts

Media:
Barnes & Noble Education
Carolyn J.
Brown
Senior Vice President
Corporate Communications & Public
Affairs
(908) 991-2967
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland

Published

on

Continue Reading

Cannabis

Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa

Published

on

Continue Reading

Innocan

Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey

Published

on

innocan-pharma-reports-breakthrough-in-a-pre-clinical-trial:-liposomal-cbd-injection-restores-mobility-to-an-amputee-female-donkey

HERZLIYA, Israel and ALGARY, AB, May 9, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the successful pre-clinical treatment with a liposomal-CBD injection in a female donkey. Innocan’s innovative therapy provided immediate noticeable pain relief and improved mobility.

Miri, a 7-year-old female donkey, underwent amputation of her right front limb at a young age, resulting in a weight burden primarily borne by her left front limb. Consequently, she developed laminitis in her left front limb, an inflammatory disease affecting the soft tissue that connects the foot bone to the hoof, seemingly causing extreme pain and limited mobility. Over time, Miri’s condition worsened, culminating in the formation of a abscess in the affected hoof, which appeared to have intensified her pain. Despite receiving pain relief medications, Miri found no respite, was unable to move, and her caregivers were advised to euthanize her.

As an act of compassionate therapy, the female donkey was administered a liposomal-CBD injection. The effect was immediate, with Miri becoming active and roaming the farm. Following the liposomal-CBD injection, the abscess in her affected foot healed, and Miri regained her ability to walk and move as she did before her laminitis developed.

“Thanks to our innovative liposomal-CBD injection, we are thrilled to have brought relief to Miri, eliminating the need for euthanasia,” commented Iris Bincovich, CEO of Innocan. “Once again, Innocan has shown liposomal-CBD to be effectively active for pain relief and well-being. We see this pre-clinical treatment as strong evidence of liposomal-CBD’s potential to improve the lives of animal patients and potentially human patients.”

“Laminitis is a crippling condition well familiar and common in horses,” said Prof Chezy Barenholz, the Chief Scientific Officer of Innocan. “The disease results in severe pain condition, representing another big market for liposomal-CBD with great potential to treat horses. Innocan is dedicated to advancing the development of CBD-based therapeutics for various indications in both humans and animals.”

For further information and a supporting video, please see: https://youtu.be/Hgqh2WOlwJQ?si=oGgSYrGi3rkW-RC

About Innocan Pharma:

Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients’ quality of life. This segment involves two drug delivery technologies: (i) LPT CBD-loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two indications: Epilepsy and Pain Management. In the Consumer Wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. that focuses developing on advanced targeted online sales. https://innocanpharma.com/

Contact Information:

For Innocan Pharma Corporation:

Iris Bincovich, CEO

+1 5162104025

+972-54-3012842

+442037699377

[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution Regarding Forward-Looking Information

Certain information set forth in this news release, including, without limitation, the Company’s plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. . The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedarplus.ca.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Logo: https://mma.prnewswire.com/media/2046271/3968398/Innocan_Pharma_Corporation_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/innocan-pharma-reports-breakthrough-in-a-pre-clinical-trial-liposomal-cbd-injection-restores-mobility-to-an-amputee-female-donkey-302141590.html

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania